The spectrum of mutations causing end-plate acetylcholinesterase deficiency
- PMID: 10665486
The spectrum of mutations causing end-plate acetylcholinesterase deficiency
Erratum in
- Ann Neurol 2000 Apr;47(4):554
Abstract
The end-plate species of acetylcholinesterase (AChE) is an asymmetric enzyme consisting of a collagenic tail subunit composed of three collagenic strands (ColQ), each attached to a tetramer of the T isoform of the catalytic subunit (AChE(T)) via a proline-rich attachment domain. The principal function of the tail subunit is to anchor asymmetric AChE in the synaptic basal lamina. Human end-plate AChE deficiency was recently shown to be caused by mutations in COLQ. We here report nine novel COLQ mutations in 7 patients with end-plate AChE deficiency. We examine the effects of the mutations on the assembly of asymmetric AChE by coexpressing each genetically engineered COLQ mutant with ACHE(T) in COS cells. We classify the newly recognized and previously reported COLQ mutations into four classes according to their position in ColQ and their effect on AChE expression. We find that missense mutations in the proline-rich attachment domain abrogate attachment of catalytic subunits, that truncation mutations in the ColQ collagen domain prevent the assembly of asymmetric AChE, that hydrophobic missense residues in the C-terminal domain prevent triple helical assembly of the ColQ collagen domain, and that other mutations in the C-terminal region produce asymmetric species of AChE that are likely insertion incompetent.
Similar articles
-
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme.Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9654-9. doi: 10.1073/pnas.95.16.9654. Proc Natl Acad Sci U S A. 1998. PMID: 9689136 Free PMC article.
-
Three novel COLQ mutations and variation of phenotypic expressivity due to G240X.Neurology. 2002 Feb 26;58(4):603-9. doi: 10.1212/wnl.58.4.603. Neurology. 2002. PMID: 11865139
-
Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.Hum Mutat. 2013 Jul;34(7):997-1004. doi: 10.1002/humu.22325. Epub 2013 Apr 19. Hum Mutat. 2013. PMID: 23553736
-
Structural and functional organization of synaptic acetylcholinesterase.Brain Res Brain Res Rev. 2004 Dec;47(1-3):96-104. doi: 10.1016/j.brainresrev.2004.07.019. Brain Res Brain Res Rev. 2004. PMID: 15572165 Review.
-
Collagen Q is a key player for developing rational therapy for congenital myasthenia and for dissecting the mechanisms of anti-MuSK myasthenia gravis.J Mol Neurosci. 2014 Jul;53(3):359-61. doi: 10.1007/s12031-013-0170-x. J Mol Neurosci. 2014. PMID: 24234034 Review.
Cited by
-
Trimerization domain of the collagen tail of acetylcholinesterase.Neurochem Res. 2003 Apr;28(3-4):523-35. doi: 10.1023/a:1022821306722. Neurochem Res. 2003. PMID: 12675141
-
COLQ-related congenital myasthenic syndrome: An integrative view.Neurogenetics. 2023 Jul;24(3):189-200. doi: 10.1007/s10048-023-00719-7. Epub 2023 May 25. Neurogenetics. 2023. PMID: 37231228
-
Current status of the congenital myasthenic syndromes.Neuromuscul Disord. 2012 Feb;22(2):99-111. doi: 10.1016/j.nmd.2011.10.009. Epub 2011 Nov 21. Neuromuscul Disord. 2012. PMID: 22104196 Free PMC article. Review.
-
Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.Int J Mol Sci. 2023 Feb 13;24(4):3730. doi: 10.3390/ijms24043730. Int J Mol Sci. 2023. PMID: 36835142 Free PMC article. Review.
-
Expression assay of the COLQ in a family with congenital myasthenic syndrome and symptomatic carriers.Clin Case Rep. 2023 Oct 23;11(10):e8062. doi: 10.1002/ccr3.8062. eCollection 2023 Oct. Clin Case Rep. 2023. PMID: 37881193 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases